July 02, 2014
The Cooper Companies, Inc. (NYSE: COO) has announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals Ltd, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 21% year-over-year. The transaction is subject to regulatory approval and is anticipated to close prior to fiscal year end, October 31, 2014.
Latham & Watkins represents The Cooper Companies in the transaction with a London-based team led by corporate partner Graeme Ward, with corporate associates Andrew Clark and Warren Fernandez. Advice has also been provided on US law matters by Silicon Valley partner Kit Kaufman; on tax matters by partner Sean Finn and associate Sinthubiravi Sivakumaran; and on employment matters by partner Stephen Brown and associates Sarah Gadd and Kendall Burnett.